Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Peckham

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Allergy and Clinical Immunology|March 1, 2011
Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosisAyman Elsheikh, Luis Castrejon, Sidonie N Lavergne, et al.
NIHR Open Research|October 26, 2023
A grumbling concern: A survey of gastrointestinal symptoms in cystic fibrosis in the modulator eraRebecca J Calthorpe, Natalie Goodchild, Vigilius Gleetus, et al.
Frontiers in Pharmacology|June 20, 2022
Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-ScoreJochen G Mainz, Carlos Zagoya, Louise Polte, et al.
Frontiers in Pharmacology|May 19, 2023
Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-ScoreJochen G Mainz, Carlos Zagoya, Louise Polte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 25, 2011
Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosisPaul Whitaker, Xiaoli Meng, Sidonie N Lavergne, et al.
The American Journal of Gastroenterology|June 2, 2021
The Perils and Pitfalls of Esophageal Dysmotility in Idiopathic Pulmonary FibrosisRamsah Cheah, Supphamat Chirnaksorn, Ahmed H Abdelrahim, et al.
Elife|March 3, 2020
Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosisHeledd H Jarosz-Griffiths, Thomas Scambler, Chi H Wong, et al.
Chemical Research in Toxicology|May 15, 2013
β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosisRosalind E Jenkins, Fiazia S Yaseen, Manal M Monshi, et al.
Neurology. Genetics|August 18, 2020
Hydrocephalus and diffuse choroid plexus hyperplasia in primary ciliary dyskinesia-related MCIDAS mutationEvie Alexandra Robson, Luke Dixon, Liam Causon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2014
European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis CentreSteven Conway, Ian M Balfour-Lynn, Karleen De Rijcke, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Allergy and Clinical Immunology|March 1, 2011
Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosisAyman Elsheikh, Luis Castrejon, Sidonie N Lavergne, et al.
NIHR Open Research|October 26, 2023
A grumbling concern: A survey of gastrointestinal symptoms in cystic fibrosis in the modulator eraRebecca J Calthorpe, Natalie Goodchild, Vigilius Gleetus, et al.
Frontiers in Pharmacology|June 20, 2022
Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-ScoreJochen G Mainz, Carlos Zagoya, Louise Polte, et al.
Frontiers in Pharmacology|May 19, 2023
Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-ScoreJochen G Mainz, Carlos Zagoya, Louise Polte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 25, 2011
Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosisPaul Whitaker, Xiaoli Meng, Sidonie N Lavergne, et al.
The American Journal of Gastroenterology|June 2, 2021
The Perils and Pitfalls of Esophageal Dysmotility in Idiopathic Pulmonary FibrosisRamsah Cheah, Supphamat Chirnaksorn, Ahmed H Abdelrahim, et al.
Elife|March 3, 2020
Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosisHeledd H Jarosz-Griffiths, Thomas Scambler, Chi H Wong, et al.
Chemical Research in Toxicology|May 15, 2013
β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosisRosalind E Jenkins, Fiazia S Yaseen, Manal M Monshi, et al.
Neurology. Genetics|August 18, 2020
Hydrocephalus and diffuse choroid plexus hyperplasia in primary ciliary dyskinesia-related MCIDAS mutationEvie Alexandra Robson, Luke Dixon, Liam Causon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2014
European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis CentreSteven Conway, Ian M Balfour-Lynn, Karleen De Rijcke, et al.
Pageof 9